전체메뉴
Article Search

VSI Vascular Specialist International

Open Access

pISSN 2288-7970
eISSN 2288-7989
QR Code QR Code

Original Article

Related articles in VSI

More Related Articles

Article

Original Article

Vasc Specialist Int (2024) 40:27

Published online August 26, 2024 https://doi.org/10.5758/vsi.240029

Copyright © The Korean Society for Vascular Surgery.

Mid-term Outcomes of Thoracic Endovascular Aortic Repair (TEVAR) in Acute Complicated Type B Aortic Dissection: A Comprehensive Analysis of Aortic Remodeling Patterns

Supong Worathanmanon1 , Pong Juntarapatin1 , Boonprasit Kritpracha1 , Wittawat Tantarattanapong1 , Dhanakom Premprapha1 , and Sorracha Rookkapan2

1Divisions of Vascular Surgery, Department of Surgery, 2Division of Interventional Radiology, Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Correspondence to:Supong Worathanmanon
Division of Vascular Surgery, Department of Surgery, Faculty of Medicine, Prince of Songkla University, 15 Karnchanavanich Road, Hat Yai, Songkhla 90110, Thailand
Tel: 66-85-081144-9
Fax: 66-74-451400
E-mail: st_master1@hotmail.com
https://orcid.org/0000-0002-9775-5893

Received: February 27, 2024; Revised: June 18, 2024; Accepted: July 7, 2024

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose: This study provides a comprehensive analysis of the clinical outcomes associated with endovascular treatment for acute complicated type B aortic dissection, with a focus on the complex process of aortic remodeling.
Materials and Methods: We conducted a retrospective investigation using data extracted from the Songklanagarind Hospital database between January 2010 and January 2022. Electronic medical records of patients who underwent thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissections were reviewed. The analysis focused on in-hospital outcomes, overall survival, aorta-related survival, reintervention-free survival, and changes in aortic lumen diameter to assess aortic remodeling.
Results: Over the study period, 32 patients with acute complicated type B aortic dissections underwent TEVAR. The in-hospital mortality rate was 9.4%, with complications occurring in 21.9% of patients. Temporary acute kidney injury was observed in 9.4% of the cases, wound bleeding in 6.3%, pneumonia in 6.3%, and permanent spinal cord ischemia in 3.1%. Re-intervention was necessary in 6.3% of cases. The overall survival rates at 6 months, 1 year, 3 years, and 6 years were 78%, 75%, 65%, and 44%, respectively. Aorta-related survival rates were 87%, 87%, 83%, and 75% at the corresponding time intervals. The reintervention-free survival rates were 96%, 96%, 71%, and 71%, respectively. Survival analysis revealed that patients with ideal aortic remodeling experienced the most favorable outcomes, whereas those with undesirable aortic remodeling exhibited the least favorable survival. Notably, undesirable pattern of aortic remodeling emerged as a singular factor with a statistically significant influence on predicting survival (hazard ratio 4.37, P-value=0.021).
Conclusion: TEVAR resulted in favorable aorta-related survival outcomes. Notably, the identification of changes in aortic lumen diameter alongside false lumen thrombosis, encapsulated within the framework of aortic remodeling patterns, has emerged as a robust predictor of post-TEVAR survival outcomes.

Keywords: Aortic dissection, Thoracic endovascular aortic repair, Mortality

INTRODUCTION

Acute type B aortic dissection, characterized by an in-hospital mortality rate of 13% and a significant 40% mortality rate in cases of acute complications, poses a significant threat to patient well-being [1,2]. While conventional management typically involves medical therapy, surgical intervention becomes imperative in complex cases, such as malperfusion, aortic rupture, refractory hypertension, and persistent pain. In recent years, endovascular treatment has emerged as a preferred approach to open aortic repair in the early stages, due to its association with reduced morbidity and mortality rates [3-5].

However, despite these advances, there remains a dearth of comprehensive reporting on the long-term outcomes of endovascular treatment, particularly concerning morphological analysis and the characteristics of aortic remodeling—a crucial factor influencing the risk of late aortic events. Existing studies on aortic remodeling after endovascular treatment for acute complicated type B aortic dissection encounter limitations stemming from the heterogeneity of remodeling measurements, diverse patient conditions (acute, subacute, or chronic), extensiveness of treatment, and restricted sample size [6-11].

This study reports the clinical outcomes of endovascular treatment in patients with acute complicated type B aortic dissections, with a follow-up period extending beyond 6 years. The primary focus is the complex process of aortic remodeling post-treatment. The insights gained from this research are intended to inform and enhance future treatment protocols for patients with this challenging vascular pathology.

MATERIALS AND METHODS

A retrospective investigation utilizing data from the Songklanagarind Hospital database was conducted to scrutinize patients with acute complicated type B aortic dissections treated with thoracic endovascular aortic repair (TEVAR). The study encompassed the period from January 2010 to January 2022, and a comprehensive review of electronic medical records was conducted. Initially, 38 patients were considered for inclusion in this study. However, computed tomography (CT) images for six patients were inaccessible via the hospital’s Picture Archiving and Communication System. As a result, the final study cohort comprised of 32 patients who met the inclusion criteria. Data compilation included variables such as age, sex, body mass index (BMI), comorbidities, tobacco use, history of previous aortic interventions, American Society of Anesthesiologists (ASA) class, aortic details, complications, in-hospital metrics, and follow-up outcomes.

1) Procedure

General anesthesia was administered, and a totally percutaneous approach to the common femoral arteries was performed, along with systemic heparinization in accordance with routine protocol. Typically, the thoracic stent-graft oversized by 0% to 10%. The primary entry tear was covered with a proximal sealing zone of 1.5-2.0 cm. In situations where achieving proximal sealing posed challenges, additional procedures, such as bypass, chimney, or fenestration of the arch branch, were performed. Coverage of the left subclavian artery without bypass was considered permissible if the patient exhibited hemodynamic instability and had a left vertebral artery diameter of less than 5 mm. For patients with malperfusion, a balloon-expandable stent graft was utilized. Surgical success was defined as the successful deployment of the stent graft at an appropriate location, effectively covering the primary tear without any proximal endoleak.

2) Follow-up

Follow-up computed tomography angiography (CTA) was conducted as part of the routine protocol at intervals of 1, 6, and 12 months, and annually thereafter. During each follow-up visit, comprehensive clinical data were meticulously documented, including the resolution of pathological conditions and symptoms, occurrence of complications, instances of re-intervention, and mortality rates.

3) Term, definition, and imaging measurement protocol

All preoperative and follow-up whole aorta CT angiograms underwent meticulous evaluation, involving measurements of the maximum true and false lumen (TL and FL) diameters, proximal and distal extension of dissection, vessel malperfusion, and endoleak during follow-up CT assessments. These measurements, which are crucial for discerning aortic remodeling, were performed by two proficient vascular surgeons (SW and PJ) [12].

The aorta is generally divided into three distinct segments for classification purposes: Section 1 encompasses the thoracic-abdominal aorta located proximally above the celiac trunk, corresponding to zones 3-5 according to established reporting standards; Section 2 comprises the abdominal aorta between the celiac trunk and renal artery, corresponding to zones 6-8; and Section 3 includes the abdominal aorta positioned distally below the renal artery, corresponding to zones 9-11. In this study, the focus was on Section 1, which encompasses the primary entry tear and stent graft placement [8,13] (Fig. 1).

Figure 1. Imaging measurement protocol was demonstrated. CA, celiac artery; SMA, superior mesenteric artery; RRA, right renal artery; LRA, left renal artery.

① Pretreatment TL and FL diameter

Assessed by measuring the maximum diameter of the TL and FL in pretreatment axial CTA images within the aortic Section 1.

② Post-treatment TL and FL diameters

Evaluated by measuring TL and FL diameters using post-treatment axial CTA images, following a routine interval protocol. These measurements were taken at the same locations as the pretreatment assessments.

③ Favorable lumen remodeling

Defined as an increase of more than 20% in the posttreatment TL diameter compared to the pretreatment TL diameter, coupled with a decrease of more than 20% in the post-treatment FL diameter compared to the pretreatment FL diameter.

④ Unfavorable lumen remodeling

Defined as a post-treatment aortic diameter measurement that did not meet the criteria for favorable aortic remodeling, as previously outlined.

⑤ Total FL thrombosis

Defined as the absence of any contrast fill-in within the FL observed on post-treatment CTA images of the aortic Section 1.

⑥ Partial FL thrombosis

Defined as the presence of any contrast fill-in within the FL observed on post-treatment CTA images of the aortic Section 1.

⑦ Aortic remodeling

Aortic remodeling was categorized into four groups based on a combination of lumen remodeling and FL thrombosis type; (1) Ideal aortic remodeling: This category comprises patients exhibiting favorable lumen remodeling and total FL thrombosis. (2). Average aortic remodeling: Patients in this category demonstrated favorable lumen remodeling along with partial FL thrombosis. (3) Undesirable aortic remodeling: Patients in this group displayed unfavorable lumen remodeling in conjunction with partial FL thrombosis. (4) Fair aortic remodeling: This category encompasses patients exhibiting unfavorable lumen remodeling and total FL thrombosis.

4) Statistical analysis

Continuous variables with a normal distribution were expressed as mean±standard deviation, while non-normally distributed variables were presented as median and interquartile range. Categorical variables were expressed as percentages. Survival analyses, including overall survival, disease-specific survival, and reintervention-free survival were performed using Kaplan-Meier curves. Additionally, a Cox regression model was used to perform multivariate survival analyses considering pertinent patient factors.

The study protocol was approved by the Human Research Ethics Committee of the Prince of Songkla University (No. REC.65-352-10-3). All statistical analyses were performed using RStudio version 1.1.456 (RStudio, Inc.), ensuring a rigorous and meticulous analytical approach in line with scholarly standards.

RESULTS

Over the past decade, 32 patients with acute complicated type B aortic dissections who underwent TEVAR at our institution were included in this study. The majority of the patients were male, with an average age of 57 years and an average BMI of 25 kg/m2. Hypertension was the predominant comorbidity. The ASA classification was predominantly Class 3, and three patients presented with aortic rupture. TEVAR was most commonly indicated due to malperfusion, particularly affecting the left renal and left lower limb vessels. The pretreatment TL and FL diameters averaged 12.9 and 27.9 mm, respectively, with more than half of the patients exhibiting distal extension of the tear to aortic zone 10 (Table 1).

Table 1 . Patients’ demographic features (n=32).

Patient’s characteristicNumber
Age (y)57.6±11.9
Male27 (84.4)
BMI (kg/m2)25 (23.4, 26.9)
Smoking26 (81.3)
Active12 (37.5)
Non-active14 (43.8)
Hypertension29 (90.6)
Diabetes4 (12.5)
COPD1 (3.1)
CAD4 (12.5)
CKD3 (9.3)
Stage 21 (3.1)
Stage 31 (3.1)
Stage 41 (3.1)
Previous aortic intervention3 (9.4)
ASA class
21 (3.1)
325 (78.1)
46 (18.8)
Indication for TEVAR
Rupture3 (9.3)
Malperfusion16 (50.0)
Right renal artery3 (18.8)
Left renal artery7 (43.8)
Celiac artery1 (6.3)
Superior mesenteric artery1 (6.3)
Right limb4 (25.0)
Left limb7 (43.8)
Spinal cord1 (6.3)
Persistent pain1 (3.1)
Uncontrolled hypertension2 (6.3)
Progressive disease13 (40.6)
Pretreatment TL diameter (mm)12.9
Pretreatment FL diameter (mm)27.9
Distal extension tear zone
53 (9.4)
72 (6.3)
95 (15.6)
1018 (56.2)
114 (12.5)

Values are presented as number (%) or mean±standard deviation..

COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CKD, chronic kidney disease; ASA, American Society of Anesthesiologists; TEVAR, thoracic endovascular aortic repair; TL, true lumen; FL, false lumen..



The Valiant thoracic stent (Medtronic Vascular) was the primary choice for almost all patients, with proximal stent deployment most frequently in zones 2 and 3, and distal stent landing predominantly in zone 5. The mean stent length was 185 cm. The average operative time was 235.0 minutes, with a median radiation time of 12 minutes. The median contrast and radiation doses were 72.5 mL and 200 mGy, respectively. A total of 68.8% of the patients underwent concomitant procedures, mainly related to achieving proximal sealing, with carotid-subclavian bypass and left subclavian coverage being the most common (Table 2).

Table 2 . Operative information.

Operative informationNumber
Valiant thoracic stent29 (90.6)
Proximal stent zone
12 (6.3)
217 (53.1)
312 (37.5)
41 (3.1)
Distal stent zone
531 (96.9)
61 (3.1)
Stent length (mm)185 (150, 200)
Operative time (min)235.0±88.5
Contrast doses (mL)72.5 (51.3, 117.0)
Radiation time (min)12.0 (9.0, 19.0)
Radiation doses (mGy)200±114
Concomitant procedure22 (68.8)
Proximal sealing related
Carotid-subclavian bypass10 (45.5)
Left subclavian artery coverage4 (18.2)
Carotid-carotid with carotid-subclavian bypass2 (9.1)
Fenestrated left subclavian artery2 (9.1)
Chimney left subclavian artery1 (4.5)
Chimney left common carotid with carotid-subclavian bypass1 (4.5)
Visceral vessel related
PTA common iliac artery2 (9.1)
Celiac stenting1 (4.5)
SMA stenting1 (4.5)
Iliac stenting1 (4.5)
Fem-fem bypass1 (4.5)

Values are presented as number (%) or mean±standard deviation..

PTA, percutaneous transluminal angioplasty; SMA, superior mesenteric artery..



The median hospitalization duration was 14.0 days, including 3.0 days in the intensive care unit and 1.0 day on mechanical ventilation. The in-hospital mortality rate was 9.4%. Among the deceased, one patient suffered hypoxic arrest due to upper airway obstruction resulting from a neck hematoma, another succumbed to septic shock caused by severe ventilator-associated pneumonia, and the final case involved multiorgan failure induced by severe reperfusion syndrome following prolonged limb ischemia. Notably, all deceased patients exhibited signs of malperfusion, with none presenting with ruptures. Complications occurred in 21.9% of the cases, including temporary acute kidney injury (AKI), wound bleeding, pneumonia, and permanent spinal cord ischemia. Reoperation was needed in 6.3% of the cases, with two patients requiring re-exploration of the neck to control bleeding. Immediate endoleaks were observed in 12.5% of cases, predominantly type 2 (Table 3).

Table 3 . In-hospital outcomes.

In-hospital outcomeNumber (%)
ICU stay (d)3.0 (1.0, 7.5)
Ventilator day (d)1.0 (0, 7.7)
Hospital stay (d)14.0 (7.0, 21.5)
Mortality3 (9.4)
Complication7 (21.9)
AKI (temporary)3 (9.4)*
Wound bleeding2 (6.3)
Pneumonia2 (6.3)
Spinal cord ischemia (permanent)1 (3.1)*
Reoperation2 (6.3)
Neck exploration with stop bleeding2 (6.3)
Immediate endoleak4 (12.5)
Type 23 (75.0)
Type 1A1 (25.0)

ICU, intensive care unit; AKI, acute kidney injury..

*One patient had AKI and spinal cord ischemia..



Table 4 shows the average changes in the aortic TL and FL diameters over a 5-year follow-up period. Of the 32 patients, 75% (24/32) demonstrated favorable lumen remodeling, while 50% (16/32) achieved total FL thrombosis. Half of the total patients exhibited favorable lumen remodeling coupled with total FL thrombosis, categorized as “ideal aortic remodeling.” Meanwhile, one-fourth of patients who displayed favorable lumen remodeling but partial FL thrombosis were classified as having “average aortic remodeling.” Conversely, 25% of patients with unfavorable lumen remodeling coupled with partial FL thrombosis were categorized as having “undesirable aortic remodeling.” Notably, no instances were recorded in which unfavorable aortic remodeling coincided with total FL thrombosis (Table 5).

Table 4 . Change in the aorta during the follow-up period.


Table 5 . Pattern of aortic change and grouping of pattern remodeling of the aorta.



Survival outcomes over the spans of 6 months, 1 year, 3 years, and 6 years are depicted in the Kaplan-Meier curve, with rates of 78% (95% confidence interval [CI], 65-93), 75% (95% CI, 61-91), 65% (95% CI, 50-84), and 44% (95% CI, 27-70), respectively (Fig. 2A). Conversely, the aorta-related survival rates at the same intervals were 87% (95% CI, 76-99), 87% (95% CI, 76-99), 83% (95% CI, 71-97), and 75% (95% CI, 58-97) (Fig. 2B). Reintervention-free survival exhibited rates of 96% (95% CI, 90-100), 96% (95% CI, 90-100), 71% (95% CI, 56-92), and 71% (95% CI, 56-92) over the specified time points (Fig. 2C).

Figure 2. Kaplan-Meier curves estimated (A) overall survival, (B) aorta-related survival, and (C) reintervention-free survival.

Most reinterventions were associated with the progression of the dissecting aneurysm, necessitating proximal and distal stent extension. There was only one case of retrograde type A dissection requiring open surgical repair. Notably, patients with unfavorable lumen remodeling demonstrated lower survival rates compared to those with favorable lumen remodeling. This trend persisted in patients with partial FL thrombosis compared to those with total FL thrombosis (Fig. 3). Within the distinct aortic remodeling groups, the Kaplan-Meier curve revealed a statistically significant survival difference. Specifically, the ideal remodeling group exhibited the highest survival rates, while the undesirable remodeling group had the lowest (P-value=0.0075). Similarly, poor aorta-related survival was observed in the cohort with undesirable aortic remodeling (P-value=0.0039; Fig. 4).

Figure 3. Kaplan-Meier curves estimated overall survival by (A) aortic remodeling, and (B) FL thrombosis. TL, true lumen; FL, false lumen.
Figure 4. Kaplan-Meier curves estimated (A) overall survival and (B) aorta-related survival by the pattern of aortic remodeling.

In Cox regression analysis, after adjusting for sex, ASA class, concomitant procedure, and rupture status factors, the undesirable aortic remodeling was identified as the sole factor with a statistically significant impact on predicting survival (adjusted hazard ratio 4.37, P-value=0.021; Table 6).

Table 6 . Cox regression analysis for predicting survival by patient factors.

Crude HR (95% CI)adjusted HR (95% CI)P (Wald’s test)
Pattern: ref.=ideal
Average1.58 (0.44-5.70)1.34 (0.30-5.93)0.697
Undesirable5.13 (1.66-15.85)4.37 (1.25-15.25)0.021
Female0.29 (0.04-2.19)0.13 (0.01-1.39)0.092
ASA class 41.02 (0.29-3.60)1.25 (0.20-7.66)0.812
Concomitant procedure1.99 (0.64-6.16)1.90 (0.47-7.73)0.368
Rupture1.64 (0.37-7.36)4.01 (0.54-29.67)0.174

HR, hazard ratio; CI, confidence interval; ASA, American Society of Anesthesiologists..


DISCUSSION

This study provides a comprehensive analysis of the TEVAR used for acute complicated type B aortic dissection at our institution. The primary indication was malperfusion, with nearly 70% of the cases requiring concomitant procedures. In-hospital complications occurred in approximately 21.9%, including AKI, bleeding, and pneumonia, while the in-hospital mortality rate was 9.4%. The overall survival rates at 6 months, 1 year, 3 years, and 6 years were 78%, 75%, 65%, and 44%, respectively. Conversely, aorta-related survival rates mirrored values of 87%, 87%, 83%, and 75%, and reintervention-free survival rates were 96%, 96%, 71%, and 71% across the corresponding time intervals. Significantly, patients who exhibited favorable lumen remodeling and total FL thrombosis demonstrated markedly better survival outcomes.

Complicated type B aortic dissection, albeit uncommon, is associated with a high in-hospital mortality rate. Despite the prominence of endovascular stent grafts as a pivotal treatment option, studies consistently report in-hospital mortality rates ranging from 7% to 11%, aligning with our center’s rate of 9.4% [13,14]. Comparisons with the International Registry of Acute Aortic Dissection (IRAD) reveal similar 5-year survival rates, emphasizing the comparable nature of our 5-year aorta-related survival rate of 83%. However, the overall survival rate of 56% is relatively low, primarily attributable to non-aortic-related causes, which account for over half of the recorded mortalities [13,15].

In-hospital complications, as reported by the IRAD, align closely with our findings, with complication rates reaching as high as 22.7%, and acute renal failure accounting for one-fourth of these complications. The similarity in outcomes may be attributed to shared indications for surgery, particularly the focus on renal artery malperfusion [13,15]. Notably, the low incidence of spinal cord ischemia, a significant concern in endovascular graft placement for complicated type B dissections, is reported at 1%-3% in recent studies [15,16]. Despite its rarity, spinal cord ischemia remains a critical and devastating condition due to the multiple risks associated with endovascular graft placement in complicated type B dissections. These risks include left subclavian artery coverage, extensive aortic involvement, hypotension, and spinal artery perfusion from the FL. Consequently, shorter stent coverage or concomitant procedures to preserve the LSCA were judiciously considered and selected to minimize the risk of spinal cord ischemia.

While much emphasis has been placed on the short- and mid-term outcomes of TEVAR for complicated type B aortic dissection, the long-term durability of stent grafts and reintervention-free survival remains a subject of debate. The IRAD reports a reintervention-free survival rate of 69.4% at 5 years, reflecting a notable decline in reintervention after 3 years, consistent with our study’s plateau rate of 71% from 3 to 6 years. Our study highlights that aneurysmal degeneration, rather than stent graft-induced distal re-dissections, is the primary cause of reintervention [13,16,17].

Aortic remodeling assessments following TEVAR have employed various methodologies, including measurement of diameter, area, and volume, as well as the evaluation of FL thrombosis. Consistent with the existing literature, our study reaffirms the association between favorable lumen remodeling and superior survival rates. Notably, we introduced a refined remodeling metric that combines aortic diameter change with FL thrombosis, which has proven to be a precise predictor of survival after TEVAR. An undesirable aortic remodeling pattern emerged as the strongest predictor of poor outcomes, as demonstrated by the Cox regression analysis, which indicated a hazard ratio of 4.37. In our study, most deaths within the undesirable remodeling group were aorta-related, with the majority occurring as in-hospital deaths. These deaths primarily resulted from postoperative complications that arose as sequelae, leading to mortality shortly after the procedure. Additionally, one patient experienced progression of the FL, resulting in mesenteric ischemia. Consequently, the Kaplan-Meier survival curve for aorta-related survival closely the overall survival curve, indicating a similar pattern in their trajectories. In our study, patients with partial FL thrombosis showed significant lower survival compared to those with total FL thrombosis. This trend may be explained by the persistent presence of dynamic blood flow within the FL, which promotes the progression of dissecting aneurysms and often necessitates subsequent reintervention. These factors likely have a detrimental effect on patient survival outcomes in the later stages of the disease. Future research should delve into the organization and management of factors influencing aortic remodeling to achieve favorable patterns and consequently enhance survival outcomes [7-11,16,18-20].

However, this study has several limitations. Its retrospective and descriptive nature poses challenges in controlling the treatment settings and patient parameters. A limited number of patients, inherent to the rarity of the disease, affected the statistical power of the analysis. Moreover, heterogeneity in data recording and unclear information in medical records presented challenges in the analysis phase. Future research should advocate systematic and intensive follow-up protocols to ensure comprehensive data management.

CONCLUSION

This study provides supporting evidence that, despite the escalating prominence of endovascular treatment as a pivotal alternative to open surgery in managing acute complicated type B aortic dissection, the associated mortality rate persists at a notable level. Nevertheless, extended examination reveals that disease-specific survival rates over an extended period are deemed acceptable. Importantly, this study identified aortic remodeling patterns, a composite metric combining changes in aortic lumen diameter with the presence of FL thrombosis, as the primary factor in predicting survival outcomes after TEVAR.

ACKNOWLEDGEMENTS

The authors thank the International Affairs Office of the Faculty of Medicine, Prince of Songkla University, for editing the English language of the manuscript.

FUNDING

None.

CONFLICTS OF INTEREST

The authors have nothing to disclose.

AUTHOR CONTRIBUTIONS

Concept and design: all authors. Analysis and interpretation: SW, PJ. Data collection: SW. Writing the article: SW, PJ. Critical revision of the article: SW, PJ. Final approval of the article: all authors. Statistical analysis: none. Obtained funding: none. Overall responsibility: SW.

Fig 1.

Figure 1.Imaging measurement protocol was demonstrated. CA, celiac artery; SMA, superior mesenteric artery; RRA, right renal artery; LRA, left renal artery.
Vascular Specialist International 2024; 40: https://doi.org/10.5758/vsi.240029

Fig 2.

Figure 2.Kaplan-Meier curves estimated (A) overall survival, (B) aorta-related survival, and (C) reintervention-free survival.
Vascular Specialist International 2024; 40: https://doi.org/10.5758/vsi.240029

Fig 3.

Figure 3.Kaplan-Meier curves estimated overall survival by (A) aortic remodeling, and (B) FL thrombosis. TL, true lumen; FL, false lumen.
Vascular Specialist International 2024; 40: https://doi.org/10.5758/vsi.240029

Fig 4.

Figure 4.Kaplan-Meier curves estimated (A) overall survival and (B) aorta-related survival by the pattern of aortic remodeling.
Vascular Specialist International 2024; 40: https://doi.org/10.5758/vsi.240029

Table 1 . Patients’ demographic features (n=32).

Patient’s characteristicNumber
Age (y)57.6±11.9
Male27 (84.4)
BMI (kg/m2)25 (23.4, 26.9)
Smoking26 (81.3)
Active12 (37.5)
Non-active14 (43.8)
Hypertension29 (90.6)
Diabetes4 (12.5)
COPD1 (3.1)
CAD4 (12.5)
CKD3 (9.3)
Stage 21 (3.1)
Stage 31 (3.1)
Stage 41 (3.1)
Previous aortic intervention3 (9.4)
ASA class
21 (3.1)
325 (78.1)
46 (18.8)
Indication for TEVAR
Rupture3 (9.3)
Malperfusion16 (50.0)
Right renal artery3 (18.8)
Left renal artery7 (43.8)
Celiac artery1 (6.3)
Superior mesenteric artery1 (6.3)
Right limb4 (25.0)
Left limb7 (43.8)
Spinal cord1 (6.3)
Persistent pain1 (3.1)
Uncontrolled hypertension2 (6.3)
Progressive disease13 (40.6)
Pretreatment TL diameter (mm)12.9
Pretreatment FL diameter (mm)27.9
Distal extension tear zone
53 (9.4)
72 (6.3)
95 (15.6)
1018 (56.2)
114 (12.5)

Values are presented as number (%) or mean±standard deviation..

COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CKD, chronic kidney disease; ASA, American Society of Anesthesiologists; TEVAR, thoracic endovascular aortic repair; TL, true lumen; FL, false lumen..


Table 2 . Operative information.

Operative informationNumber
Valiant thoracic stent29 (90.6)
Proximal stent zone
12 (6.3)
217 (53.1)
312 (37.5)
41 (3.1)
Distal stent zone
531 (96.9)
61 (3.1)
Stent length (mm)185 (150, 200)
Operative time (min)235.0±88.5
Contrast doses (mL)72.5 (51.3, 117.0)
Radiation time (min)12.0 (9.0, 19.0)
Radiation doses (mGy)200±114
Concomitant procedure22 (68.8)
Proximal sealing related
Carotid-subclavian bypass10 (45.5)
Left subclavian artery coverage4 (18.2)
Carotid-carotid with carotid-subclavian bypass2 (9.1)
Fenestrated left subclavian artery2 (9.1)
Chimney left subclavian artery1 (4.5)
Chimney left common carotid with carotid-subclavian bypass1 (4.5)
Visceral vessel related
PTA common iliac artery2 (9.1)
Celiac stenting1 (4.5)
SMA stenting1 (4.5)
Iliac stenting1 (4.5)
Fem-fem bypass1 (4.5)

Values are presented as number (%) or mean±standard deviation..

PTA, percutaneous transluminal angioplasty; SMA, superior mesenteric artery..


Table 3 . In-hospital outcomes.

In-hospital outcomeNumber (%)
ICU stay (d)3.0 (1.0, 7.5)
Ventilator day (d)1.0 (0, 7.7)
Hospital stay (d)14.0 (7.0, 21.5)
Mortality3 (9.4)
Complication7 (21.9)
AKI (temporary)3 (9.4)*
Wound bleeding2 (6.3)
Pneumonia2 (6.3)
Spinal cord ischemia (permanent)1 (3.1)*
Reoperation2 (6.3)
Neck exploration with stop bleeding2 (6.3)
Immediate endoleak4 (12.5)
Type 23 (75.0)
Type 1A1 (25.0)

ICU, intensive care unit; AKI, acute kidney injury..

*One patient had AKI and spinal cord ischemia..


Table 4 . Change in the aorta during the follow-up period.


Table 5 . Pattern of aortic change and grouping of pattern remodeling of the aorta.


Table 6 . Cox regression analysis for predicting survival by patient factors.

Crude HR (95% CI)adjusted HR (95% CI)P (Wald’s test)
Pattern: ref.=ideal
Average1.58 (0.44-5.70)1.34 (0.30-5.93)0.697
Undesirable5.13 (1.66-15.85)4.37 (1.25-15.25)0.021
Female0.29 (0.04-2.19)0.13 (0.01-1.39)0.092
ASA class 41.02 (0.29-3.60)1.25 (0.20-7.66)0.812
Concomitant procedure1.99 (0.64-6.16)1.90 (0.47-7.73)0.368
Rupture1.64 (0.37-7.36)4.01 (0.54-29.67)0.174

HR, hazard ratio; CI, confidence interval; ASA, American Society of Anesthesiologists..


References

  1. Lauterbach SR, Cambria RP, Brewster DC, Gertler JP, Lamuraglia GM, Isselbacher EM, et al. Contemporary management of aortic branch compromise resulting from acute aortic dissection. J Vasc Surg 2001;33:1185-1192. https://doi.org/10.1067/mva.2001.115377.
    Pubmed CrossRef
  2. Suzuki T, Mehta RH, Ince H, Nagai R, Sakomura Y, Weber F, et al; International Registry of Aortic Dissection. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation 2003;108 Suppl 1:II312-II317. https://doi.org/10.1161/01.cir.0000087386.07204.09.
    Pubmed CrossRef
  3. Alfson DB, Ham SW. Type B aortic dissections: current guidelines for treatment. Cardiol Clin 2017;35:387-410. https://doi.org/10.1016/j.ccl.2017.03.007.
    Pubmed CrossRef
  4. Jordan F, FitzGibbon B, Kavanagh EP, McHugh P, Veerasingam D, Sultan S, et al. Endovascular versus open surgical repair for complicated chronic type B aortic dissection. Cochrane Database Syst Rev 2021;12:CD012992. https://doi.org/10.1002/14651858.cd012992.pub2.
    Pubmed KoreaMed CrossRef
  5. Hsieh RW, Hsu TC, Lee M, Hsu WT, Chen ST, Huang AH, et al. Comparison of type B dissection by open, endovascular, and medical treatments. J Vasc Surg 2019;70:1792-1800.e3. https://doi.org/10.1016/j.jvs.2019.02.062.
    Pubmed CrossRef
  6. Stanley GA, Murphy EH, Knowles M, Ilves M, Jessen ME, Dimaio JM, et al. Volumetric analysis of type B aortic dissections treated with thoracic endovascular aortic repair. J Vasc Surg 2011;54:985-992; discussion 992. https://doi.org/10.1016/j.jvs.2011.03.263.
    Pubmed CrossRef
  7. Leshnower BG, Duwayri YM, Chen EP, Li C, Zehner CA, Binongo JN, et al. Aortic remodeling after endovascular repair of complicated acute type B aortic dissection. Ann Thorac Surg 2017;103:1878-1885. https://doi.org/10.1016/j.athoracsur.2016.09.057.
    Pubmed CrossRef
  8. Huang CY, Hsu HL, Chen PL, Kuo TT, Chen IM, Hsu CP, et al. Aortic remodeling after hybrid provisional extension to induce complete attachment aortic repair of chronic residual type I aortic dissection. J Thorac Cardiovasc Surg 2019;158:1007-1016. https://doi.org/10.1016/j.jtcvs.2018.12.041.
    Pubmed CrossRef
  9. Mohamed HA, Tawfik AR, Ali M, Ali RK. Aortic remodeling after thoracic endovascular repair of acute uncomplicated type B aortic dissection. Egypt J Surg 2019;38:239-244.
  10. Kim KM, Donayre CE, Reynolds TS, Kopchok GE, Walot I, Chauvapun JP, et al. Aortic remodeling, volumetric analysis, and clinical outcomes of endoluminal exclusion of acute complicated type B thoracic aortic dissections. J Vasc Surg 2011;54:316-324; discussion 324-325. https://doi.org/10.1016/j.jvs.2010.11.134.
    Pubmed CrossRef
  11. Zhou Y, Wang WC, Zhang XM, Yang C, Zheng J, Yang L, et al. Aortic remodelling after thoracic endovascular aortic repair for acute and subacute type B aortic dissection. Quant Imaging Med Surg 2018;8:391-398. https://doi.org/10.21037/qims.2018.05.03.
    Pubmed KoreaMed CrossRef
  12. Mani K. Aortic remodeling after TEVAR for type B dissection: time for consensus definition. J Endovasc Ther 2014;21:526-528. https://doi.org/10.1583/13-4646c.1.
    Pubmed CrossRef
  13. Li Z, Wang X, He Y, Xiang Y, Wu Z, Zhang H, et al. Long-term aortic remodeling after thoracic endovascular aortic repair of acute, subacute, and chronic type B dissections. Front Cardiovasc Med 2022;9:819501. https://doi.org/10.3389/fcvm.2022.819501.
    Pubmed KoreaMed CrossRef
  14. Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD, Sechtem U, et al; IRAD Investigators. Insights from the International Registry of Acute Aortic Dissection: a 20-year experience of collaborative clinical research. Circulation 2018;137:1846-1860. https://doi.org/10.1161/circulationaha.117.031264.
    Pubmed CrossRef
  15. Tsai TT, Fattori R, Trimarchi S, Isselbacher E, Myrmel T, Evangelista A, et al; International Registry of Acute Aortic Dissection. Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation 2006;114:2226-2231. https://doi.org/10.1161/circulationaha.106.622340.
    Pubmed CrossRef
  16. Fattori R, Montgomery D, Lovato L, Kische S, Di Eusanio M, Ince H, et al. Survival after endovascular therapy in patients with type B aortic dissection: a report from the International Registry of Acute Aortic Dissection (IRAD). JACC Cardiovasc Interv 2013;6:876-882. https://doi.org/10.1016/j.jcin.2013.05.003.
    Pubmed CrossRef
  17. Zhang H, Qiao T. Aortic remodeling in type B aortic dissection after thoracic endovascular aortic repair with an aortic extender cuff implantation. Clin Interv Aging 2018;13:2359-2366. https://doi.org/10.2147/cia.s179526.
    Pubmed KoreaMed CrossRef
  18. Kato N, Hirano T, Kawaguchi T, Ishida M, Shimono T, Yada I, et al. Aneurysmal degeneration of the aorta after stent-graft repair of acute aortic dissection. J Vasc Surg 2001;34:513-518. https://doi.org/10.1067/mva.2001.116971.
    Pubmed CrossRef
  19. Sayer D, Bratby M, Brooks M, Loftus I, Morgan R, Thompson M. Aortic morphology following endovascular repair of acute and chronic type B aortic dissection: implications for management. Eur J Vasc Endovasc Surg 2008;36:522-529. https://doi.org/10.1016/j.ejvs.2008.06.023.
    Pubmed CrossRef
  20. Wang R, Kan Y, Yang M, Zhang H, Zhang X, Dai X, et al. Clinical results and aortic remodeling after endovascular treatment for complicated type B aortic dissection with the "fabulous" stent system. Front Cardiovasc Med 2022;9:817675. https://doi.org/10.3389/fcvm.2022.817675.
    Pubmed KoreaMed CrossRef